Pancreatic cancer, the most deadly and silent: what I see when it finally arrives at the ICU

A few weeks ago, a Spanish scientist published work that raised the possibility of eradicating pancreatic cancer in mice. There were applause, headlines — and, on social media, people mocking the shape of his face instead of registering the magnitude of what he was trying to do. I want to talk about that disease, because I don’t meet pancreatic cancer in conferences. I meet it in the intensive care unit, when it’s too late. The patient arrives jaundiced — eyes and skin yellow — with abdominal pain, profound weight loss, infections, clots and multi-organ failure. By the time the family understands what’s happening, we have hours, not weeks.

What pancreatic adenocarcinoma is, in plain language

The pancreas sits deep in the upper abdomen, behind the stomach. It has two big jobs: producing digestive enzymes that travel through tiny ducts into the duodenum, and producing hormones — insulin, glucagon — that regulate blood sugar.

About 90 % of pancreatic cancers are ductal adenocarcinomas: they originate inside those tiny ducts, deep in the gland. That detail is what makes them so dangerous. They don’t grow on a surface where you might feel them or where they would press on something early. They grow inside a pipe, quietly, surrounded by other organs that hide them from any imaging done without a specific reason. By the time you see smoke, the inside of the wall is already burning.

Why this cancer is so aggressive

Pancreatic adenocarcinoma isn’t just hard to find. It is biologically built to survive everything we throw at it:

Early mutations — KRAS, TP53 and others — appear very soon in the tumor’s life and create cells that are difficult to kill.
A fibrous microenvironment — the tumor builds a dense protective shell of scar-like tissue around itself, blocking chemotherapy from reaching the cells.
Immune evasion — the cancer chemically convinces the immune system to leave it alone.
High recurrence — because the fibrous shell shelters a few surviving cells, the tumor often comes back even after technically successful treatment.

This isn’t a story of oncologists not knowing what to do. It’s a story of a cancer that is designed, biologically, to resist what oncologists know how to do.

How it destroys the body

Once it grows, the damage runs through three corridors at once:

Digestive collapse. The tumor blocks the ducts that carry digestive enzymes into the gut. The patient eats but cannot absorb. They begin to consume their own muscle and fat to survive — a state we call cachexia.
Bile obstruction. The head of the pancreas sits next to the common bile duct. A growing mass compresses that duct, bile can’t drain, and the patient turns yellow as bilirubin builds up in the blood. That bile reservoir also gets infected and can drive sepsis.
New-onset diabetes. Because insulin production is part of the pancreas’s job, a tumor in the gland can disrupt it. New-onset diabetes in an adult over 50, especially with weight loss, is one of the signals that should never be brushed off.

When the body screams, the cancer was already speaking months ago.

By the time the patient arrives at the ICU, the disease is rarely a clean clinical picture. It is jaundice + cachexia + thrombosis + infection + pain + fear, all at once.

Why it is found so late

Pancreatic cancer doesn’t hurt at the start. It doesn’t bleed visibly. It doesn’t change the color of urine until the bile duct is already compressed. The classic late symptoms — persistent abdominal pain, unexplained weight loss, jaundice, new-onset diabetes after 50, fatty stools — are what we call late signs precisely because they show up after the tumor is large enough to disturb the neighborhood.

There is no useful screening for the general population yet. What we do have is risk stratification. The factors that consistently raise the odds:

Smoking — by far the strongest modifiable risk factor.
Visceral obesity and metabolic syndrome.
Poorly controlled diabetes for many years.
Chronic heavy alcohol intake.
Chronic pancreatitis.
Sedentary lifestyle.
Age over 50, with a strong family history of pancreatic cancer.

None of those are punishment. They are biology responding to sustained inputs.

What prevention actually looks like

Prevention is not paranoia. It is respect for a body that runs on biology, not luck. The things that lower lifetime risk are the same ones that lower cardiovascular and metabolic risk:

Don’t smoke. Quitting at any age lowers the risk meaningfully over the following decade.
Keep visceral fat in check. A tape measure around the waist tells you more than the scale.
Move your body regularly. At least 150 minutes a week of moderate activity.
Treat metabolic disease early. A poorly controlled diabetes is years of damage; an early, well-controlled one is not. Our course on diabetes care covers how to read your own glucose curve before the gland gets exhausted.
Limit alcohol to occasional, moderate intake.
Don’t normalize persistent symptoms. Weeks of upper abdominal pain, unexplained weight loss, painless jaundice or new-onset adult diabetes deserve an investigation, not reassurance.

If you want to understand the bigger pattern — how chronic metabolic disease ends up in the ICU as cancer, infarction or organ failure — our Real ICU cases pillar collects the stories that connect the kitchen to the unit.